Clinical trials: Cough Hypersensitivity Syndrome

Cough

Cough Desensitization Therapy for Cough Hypersensitivity Syndrome

• Completed
• Age: 18 to 99 years
• Early Phase 1
• Results posted

The purpose of this study is to investigate a modified behavioral treatment for chronic cough due to cough hypersensitivity syndrome (CHS).

Trial name

NCT04256733

Testing

Supra-threshold and progressive doses of diluted capsaicin via a Koko Digidoser nebulizer, Sub-threshold doses of diluted capsiacin via a KoKo Digidoser nebulizer

Where

United States

Volunteers

19 people

Sponsor

University of Montana